Bard Avaulta Transvaginal Mesh. If you received the C.R. Bard Avaulta mesh system during surgery to repair pelvic prolapse or treat urinary incontinence, you may be at risk for erosion, extrusion, hardening and shrinkage of the mesh materials. This can cause severe and persistent pain, infection and the need for additional surgical procedures to remove the Bard Avaulta mesh.
A growing number of lawsuits over the Bard Avaulta vaginal mesh have been filed in courts throughout the US. These lawsuits allege that C.R. Bard was negligent in the product’s design and in failing to warn patients of possible complications with Bard Avaulta mesh.
Some doctors have also been named in these lawsuits, which also claim that the Bard Avaulta mesh was improperly and negligently implanted in patients.
It is believed that the Bard Avaulta surgical mesh design inhibits surrounding tissue from receiving nutrients and oxygen, causing impaired healing. This can lead to complications that may require further surgery.
Possible Bard Avaulta Complications and Injuries:
- Erosion of the mesh through the vaginal tissue
- Exposure or extrusion of mesh, which can require multiple surgeries
- Feeling a lump in the vaginal opening or something protruding from vagina
- Painful sexual intercourse
- Perforation or puncture of the bladder, intestines and bowels, as well as blood vessels around the vaginal wall
- Recurrent Pelvic Organ Prolapse (POP)
- Recurrent Stress Urinary Incontinence (SUI)
- Urinary problems
- Vaginal bleeding
- Vaginal chronic drainage, discharge and infections
- Vaginal pain
- Vaginal scarring and shortening
Complete Bard Avaulta mesh removal often requires multiple surgical procedures and results in scarring of pelvic tissue and muscles. Unfortunately, complications from the implantation of a Bard Avaulta mesh can lead to a serious decline in the patient’s quality of life.
C.R. Bard Avaulta MultiDistrict Litigation (MDL)
In October 2010, the U.S. Judicial Panel on Multidistrict Litigation consolidated all federal lawsuits involving C.R. Bard’s Avaulta Biosynthetic, Avaulta Plus and Avaulta Solo transvaginal mesh products in a multidistrict litigation (MDL), the Avaulta Pelvic Support Systems Product Liability Litigation (MDL 2187).
The C.R. Bard Avaulta MDL is currently pending in U.S. District Court, Southern District of West Virginia before the Honorable Joseph R. Goodwin. Plaintiffs with lawsuits pending in the C.R. Bard Avaulta MDL allege that these surgical mesh devices were defectively designed and caused them to sustain serious injuries, including erosion, extrusion, dyspareunia, and pain.
Plaintiffs further allege the defendants failed to warn of the extent and types of injuries, or that the discomfort caused by transvaginal mesh complications could be permanent, even after multiple corrective surgeries.
An MDL allows lawsuits associated with a particular product to be coordinated under one judge for pretrial litigation to avoid duplicative discovery, inconsistent rulings and to conserve the resources of the parties, witnesses and the court.
When lawsuits are consolidated as a multidistrict litigation, each retains its own identity. If lawsuits in the C.R. Bard Avaulta MDL are not resolved, they will be transferred back to the court where they originated for trial.
Need Legal Help Regarding Bard Avaulta Transvaginal Mesh?
If you are among the women suffering because of the Bard Avaulta mesh, we can help. For a free legal consultation with one of our defective medical device attorneys, please fill out our online form or call 1-800-YOURLAWYER (1-800-968-7529).